沃华医药
(002107)
| 流通市值：37.71亿 | | | 总市值：38.21亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 425,358,485.78 | 217,836,836.34 | 763,793,394.09 | 576,678,675.17 |
| 营业收入 | 425,358,485.78 | 217,836,836.34 | 763,793,394.09 | 576,678,675.17 |
| 二、营业总成本 | 383,615,906.86 | 197,061,679.26 | 721,591,576.18 | 554,004,849.28 |
| 营业成本 | 109,473,266.18 | 58,798,116.12 | 209,521,291.37 | 159,899,955.56 |
| 税金及附加 | 7,272,990.07 | 3,669,994.46 | 12,902,286.56 | 9,553,006.4 |
| 销售费用 | 214,620,640.12 | 106,676,380.13 | 388,708,092.15 | 302,748,648.37 |
| 管理费用 | 34,110,587.74 | 18,734,775.31 | 74,667,869.77 | 56,290,696.75 |
| 研发费用 | 20,317,040.72 | 10,272,308.35 | 40,650,174.79 | 29,383,363.35 |
| 财务费用 | -2,178,617.97 | -1,089,895.11 | -4,858,138.46 | -3,870,821.15 |
| 其中:利息费用 | 36,330.2 | 19,235.68 | 15,953.21 | 5,816.5 |
| 其中:利息收入 | 2,225,057.59 | 1,111,686.76 | 4,932,968.75 | 3,915,939.43 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 820,176.99 | - | - | - |
| 资产减值损失(新) | -1,545,569.11 | -116,084.36 | -1,305,451.05 | -867,044.08 |
| 信用减值损失(新) | 4,087,598.58 | 4,191,171.55 | -1,856,849.42 | 679,741.77 |
| 其他收益 | 2,085,452.2 | 1,249,200.19 | 5,546,054.53 | 3,948,480.19 |
| 四、营业利润 | 47,190,237.58 | 26,099,444.46 | 44,585,571.97 | 26,435,003.77 |
| 加:营业外收入 | 109,973.15 | 37,071.5 | 456,979.12 | 262,236.31 |
| 减:营业外支出 | 273,876.55 | 41,486.86 | 2,395,179.81 | 1,526,085.17 |
| 五、利润总额 | 47,026,334.18 | 26,095,029.1 | 42,647,371.28 | 25,171,154.91 |
| 减:所得税费用 | 5,848,669.96 | 3,982,823.47 | 8,888,830.4 | 5,031,960.61 |
| 六、净利润 | 41,177,664.22 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 41,317,625.65 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 |
| 终止经营净利润 | -139,961.43 | - | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,676,392.95 | 22,859,812.88 | 36,403,379.34 | 22,909,628.29 |
| 少数股东损益 | -3,498,728.73 | -747,607.25 | -2,644,838.46 | -2,770,433.99 |
| 扣除非经常损益后的净利润 | 42,735,464.72 | 22,057,608.04 | 34,343,146.11 | 21,284,019.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.04 | 0.06 | 0.04 |
| (二)稀释每股收益 | 0.08 | 0.04 | 0.06 | 0.04 |
| 九、综合收益总额 | 41,177,664.22 | 22,112,205.63 | 33,758,540.88 | 20,139,194.3 |
| 归属于母公司股东的综合收益总额 | 44,676,392.95 | 22,859,812.88 | 36,403,379.34 | 22,909,628.29 |
| 归属于少数股东的综合收益总额 | -3,498,728.73 | -747,607.25 | -2,644,838.46 | -2,770,433.99 |
| 公告日期 | 2025-07-22 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |